MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinomaTetsu Tomonari, Tetsuji Takayama|Oncotarget|2016Cited by 66
EGFR Downregulation after Anti-EGFR Therapy Predicts the Antitumor Effect in Colorectal CancerYasuyuki Okada, Tetsuji Takayama|Molecular Cancer Research|2017Cited by 62
High antitumor activity of pladienolide B and its derivative in gastric cancerMomoko Sato, Tetsuji Takayama|Cancer Science|2013Cited by 52
A Novel Theranostic Combination of Near-infrared Fluorescence Imaging and Laser Irradiation Targeting c-KIT for Gastrointestinal Stromal TumorsShota Fujimoto, Tetsuji Takayama|Theranostics|2018Cited by 33
MiR-125b-5p Is Involved in Sorafenib Resistance through Ataxin-1-Mediated Epithelial-Mesenchymal Transition in Hepatocellular CarcinomaAkihiro Hirao, Tetsuji Takayama|Cancers|2021Cited by 32